INIS
nervous system diseases
100%
brain
56%
proteins
51%
hepatomas
44%
humans
41%
mice
32%
aggregation
32%
hepatocytes
30%
toxicity
28%
patients
27%
cancer
24%
liver
24%
diseases
24%
rna
22%
levels
20%
immunotherapy
18%
tissues
16%
transformations
16%
interactions
15%
neurons
15%
strains
14%
dna
14%
pathology
14%
texas
14%
dna damages
14%
air pollution
14%
growth
13%
phenotype
11%
monoclonal antibodies
11%
chromatin
11%
in vivo
11%
comparative evaluations
10%
genes
10%
control
9%
microtubules
9%
pathogenesis
9%
age dependence
8%
inflammation
8%
risks
8%
proliferation
8%
therapy
8%
molecules
8%
messenger-rna
8%
animals
8%
injuries
8%
migration
7%
biology
7%
tar
7%
interventions
7%
mitochondria
7%
Biochemistry, Genetics and Molecular Biology
Tau
65%
Mouse Model
15%
Glypican 3
14%
RNA-binding Protein
14%
Mouse
11%
Age
10%
Phenotype
10%
Protein
9%
Species
9%
Aging
9%
Spliceosome
7%
Small Extracellular Vesicles
7%
Lysine
7%
Lamin
7%
Small Molecule
7%
Transcription
7%
Ubiquitination
7%
Synapse
7%
Hepatocyte
7%
Growth
7%
Polyadenylation
7%
Z-DNA
7%
Transgenic Mouse
7%
High-Mobility Group
7%
Chromatin Remodeling
7%
DNA Damage Response
7%
Messenger RNA
7%
P53
7%
Attenuation
7%
Senescence
7%
Keyphrases
Tauopathy
14%
Tau Oligomers
14%
Alzheimer's Disease
8%
Cognitive Function
8%
Bioartificial Organs
7%
Mouse Model
7%
Small Extracellular Vesicles
7%
Myocardial Diastolic Dysfunction
7%
Human tau
7%
Frontotemporal Dementia
7%
Passive Immunity
7%
Co-conformations
7%
Musashi2
7%
Big tau
7%
Microtubule Tyrosination
7%
Hazardous Air Pollutants
7%
Z-DNA Binding Protein
7%
TAR DNA-binding Protein 43 (TDP-43)
7%
Oligomeric
7%
Amyotrophic Lateral Sclerosis
7%
Nasal
7%
Specific Monoclonal Antibodies
7%
Aged Persons
7%
Tau Pathology
7%
Tau Conformation
7%
Nuclear Alterations
7%
Tau Immunotherapy
7%
Retinal Vascular Plexus
7%
P53 Aggregation
7%